CMV DNA Quantitative

Function

The Cytomegalovirus (CMV) DNA Quantitative test, often performed via Polymerase Chain Reaction (PCR), measures the actual viral load (the amount of CMV DNA) present in the patient's blood. CMV is a member of the herpesvirus family. In healthy individuals, the immune system usually keeps the virus dormant after an initial infection. However, in immunocompromised individuals, the virus can reactivate and cause severe systemic disease.

Why it is Ordered

This test is primarily used to monitor patients who are at high risk for CMV disease, such as organ transplant recipients, bone marrow transplant patients, and individuals with advanced HIV/AIDS. It is used to:

• Diagnose an active CMV infection.
• Monitor the effectiveness of antiviral therapy (e.g., Ganciclovir).
• Predict the risk of CMV-related organ damage (like pneumonia, hepatitis, or retinitis) before symptoms appear.

Associated Conditions

• CMV Syndrome: Characterized by fever, malaise, and leukopenia in transplant patients.
• Invasive CMV Disease: Including CMV Colitis, CMV Pneumonitis, and CMV Retinitis.
• Congenital CMV: In newborns, though usually tested via urine or saliva.
• Mononucleosis-like Syndrome: In immunocompetent adults during primary infection.